Bond™ PA0790
by Leica Biosystems Newcastle, Limited
Ref PA0790
Bond PA0790 is a tumour necrosis factor receptor superfamily IVD (EU IVDD general IVD; FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Leica Biosystems Newcastle, Limited, registered in EUDAMED on 5 Jun 2026 (Basic UDI-DI B-05055331303820) and listed in FDA GUDID since 19 Mar 2021 (UDI-DI 05055331303820), active as of 22 Oct 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-05055331303820 05055331303820 | Date5 Jun 2026 | StatusActive |
| United States | GUDID listing GUDID | Number05055331303820 | Date19 Mar 2021 | StatusListed |
Official records
- EUDAMED public site B-05055331303820
- AccessGUDID record 05055331303820
From the FDA record
- Device description
- CD30 (JCM182) monoclonal antibody is intended to be used for the qualitative identification by light microscopy of CD30 protein in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated BOND system (includes Leica BOND-MAX system and Leica BOND-III system).
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-05055331303820 registered 5 Jun 2026 Active
- FDA GUDID UDI-DI 05055331303820 listed 19 Mar 2021 Listed
Timeline
- Listed FDA GUDID 05055331303820
- Registered EUDAMED B-05055331303820
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- CD30 JCM182 7 mL EUDAMEDBond™ GUDID
- Generic name
- Tumour necrosis factor receptor superfamily IVD, antibody
- Device name
- BOND Ready-to-Use Primary Antibody CD30 (JCM182)
- Model / Ref / Catalog
- PA0790
- Primary DI / UDI-DI
- 05055331303820
- Basic UDI-DI
- B-05055331303820
- FDA product code
- NJT
- EMDN code
- W01030709 Primary antisera for immunohistology
- GMDN term
- Tumour necrosis factor receptor superfamily IVD, antibody
- Device class
- Class IVD General EUDAMEDClass I GUDID
- Regulation number
- 864.1860
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Germany
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class IVD General | Class I |
Similar devices in this category
Other devices filed under PRIMARY ANTISERA FOR IMMUNOHISTOLOGY.
- Peripherin (8G2) Mouse Monoclonal Antibody 476M-15 by CELL MARQUE CORPORATION
- Collagen IV Z2410RS by Zeta Corporation
- CEA Rabbit Polyclonal Antibody 236A-16 by CELL MARQUE CORPORATION
- CD30 Antibody Reagent (Immunohistochemistry) RMF1A056 by Shenzhen Dartmon Biotechnology Co., Ltd.
- Langerin Z2700RP by Zeta Corporation
- PTEN Antibody Reagent (Immunohistochemistry) DMRD0590 by Shenzhen Dartmon Biotechnology Co., Ltd.
- Tinto Chromogranin A, LK2H10, MMab BSB 5344 by BIO SB, INC.
- Tinto CD43, MT1, MMab BSB 5239 by BIO SB, INC.
- STAT6 Antibody (Immunohistochemistry) 3ml by Xiamen Talent Biomedical Technology Co.,Ltd
- PTEN Antibody (Immunohistochemistry) 1ml by Xiamen Talent Biomedical Technology Co.,Ltd